HRP20050308A2 - Chirale oxazole-arylpropionic acid derivatives and their use as ppar agonists - Google Patents

Chirale oxazole-arylpropionic acid derivatives and their use as ppar agonists

Info

Publication number
HRP20050308A2
HRP20050308A2 HR20050308A HRP20050308A HRP20050308A2 HR P20050308 A2 HRP20050308 A2 HR P20050308A2 HR 20050308 A HR20050308 A HR 20050308A HR P20050308 A HRP20050308 A HR P20050308A HR P20050308 A2 HRP20050308 A2 HR P20050308A2
Authority
HR
Croatia
Prior art keywords
chirale
oxazole
acid derivatives
ppar agonists
arylpropionic acid
Prior art date
Application number
HR20050308A
Other languages
English (en)
Croatian (hr)
Inventor
Binggeli Alfred
Boehringer Markus
Grether Uwe
Hilpert Hans
Hirth Georges
Maerki Hans-Peter
Meyer Markus
Mohr Peter
Ricklin Fabienne
Original Assignee
F. Hoffmann - La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann - La Roche Ag filed Critical F. Hoffmann - La Roche Ag
Publication of HRP20050308A2 publication Critical patent/HRP20050308A2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR20050308A 2002-10-07 2003-10-06 Chirale oxazole-arylpropionic acid derivatives and their use as ppar agonists HRP20050308A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02022286 2002-10-07
PCT/EP2003/011030 WO2004031162A1 (en) 2002-10-07 2003-10-06 Chirale oxazole-arylpropionic acid derivatives and their use as ppar agonists

Publications (1)

Publication Number Publication Date
HRP20050308A2 true HRP20050308A2 (en) 2006-07-31

Family

ID=32049977

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20050308A HRP20050308A2 (en) 2002-10-07 2003-10-06 Chirale oxazole-arylpropionic acid derivatives and their use as ppar agonists

Country Status (31)

Country Link
US (2) US6969725B2 (de)
EP (1) EP1551814B1 (de)
JP (1) JP4414886B2 (de)
KR (1) KR100623819B1 (de)
CN (1) CN100415727C (de)
AR (1) AR041481A1 (de)
AT (1) ATE402153T1 (de)
AU (1) AU2003273949B2 (de)
BR (1) BR0315114A (de)
CA (1) CA2499721C (de)
CO (1) CO5540385A2 (de)
DE (1) DE60322408D1 (de)
DK (1) DK1551814T3 (de)
ES (1) ES2311110T3 (de)
GT (1) GT200300218A (de)
HR (1) HRP20050308A2 (de)
IL (1) IL167250A (de)
MX (1) MXPA05003392A (de)
MY (1) MY143576A (de)
NO (1) NO330171B1 (de)
NZ (1) NZ538465A (de)
PA (1) PA8584501A1 (de)
PE (1) PE20040591A1 (de)
PL (1) PL208743B1 (de)
PT (1) PT1551814E (de)
RU (1) RU2303593C2 (de)
SI (1) SI1551814T1 (de)
TW (1) TWI343915B (de)
UY (1) UY28006A1 (de)
WO (1) WO2004031162A1 (de)
ZA (1) ZA200502664B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105551B2 (en) * 2000-12-20 2006-09-12 Smithkline Beecham Corporation Thiazole derivatives for treating PPAR related disorders
TWI343915B (en) * 2002-10-07 2011-06-21 Hoffmann La Roche Chirale ppar agonists
EP1569916B1 (de) * 2002-11-15 2009-01-07 Cadila Healthcare Ltd. Substituierte aralkyl verbindungen
US7262303B2 (en) * 2003-09-29 2007-08-28 Hoffman-La Roche Inc. Process for the production of chiral propionic acid derivatives
GB2460784A (en) * 2007-03-07 2009-12-16 Dong A Pharmtech Co Ltd Novel phenylpropionic acid derivatives as peroxisome proliferator-activated gamma receptor modulators,method of the same,and pharmaceutical composition
RU2361581C2 (ru) 2007-09-14 2009-07-20 Закрытое Акционерное Общество "Мастерклон" Фармацевтическая композиция, обладающая противодиабетической, гиполипидемической, гипогликемической и гипохолестеринемической активностью, способ ее получения и способы лечения указанных заболеваний
JP2012506386A (ja) * 2008-10-21 2012-03-15 メタボレックス， インコーポレイテッド アリールｇｐｒ１２０受容体アゴニストおよびその使用
AR074760A1 (es) 2008-12-18 2011-02-09 Metabolex Inc Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico.
CN101805337B (zh) * 2009-02-13 2012-05-23 天津药物研究院 一类含脯氨酸和异恶唑骨架的化合物、其制备方法和用途
CN101805336B (zh) * 2009-02-13 2012-05-30 天津药物研究院 一类含色氨酸和异恶唑骨架的化合物、其制备方法和用途
US8637096B2 (en) 2009-12-04 2014-01-28 Curtis C. Stojan Compositions and method for enhancing insulin activity
US8299117B2 (en) 2010-06-16 2012-10-30 Metabolex Inc. GPR120 receptor agonists and uses thereof
CN102285933B (zh) * 2010-06-18 2016-03-09 浙江海正药业股份有限公司 一种对亚型过氧化物酶增殖物激活受体具有激动作用的化合物、其制备方法和应用
WO2013041621A1 (de) 2011-09-20 2013-03-28 Basf Se Niedermolekulare modulatoren des kälte-menthol-rezeptors trpm8 und deren verwendung

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089514A (en) * 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
GB9604242D0 (en) * 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
IL128600A0 (en) * 1996-08-19 2000-01-31 Japan Tobacco Inc Propionic acid derivatives and pharmaceutical compositions containing them
CZ296507B6 (cs) * 1998-03-30 2006-03-15 Japan Tobacco Inc. Zpusob výroby oxazolylethanolových derivátu
MY123337A (en) * 1998-05-11 2006-05-31 Takeda Chemical Industries Ltd Oxyiminoalkanoic acid derivatives.
GB9817118D0 (en) * 1998-08-07 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
CZ20013593A3 (cs) * 1999-04-06 2002-03-13 Sankyo Company, Limited Alfa-Substituované deriváty karboxylových kyselin
TW200528436A (en) 1999-09-22 2005-09-01 Bristol Myers Squibb Co Substituted acid derivatives useful as antiodiabetic and antiobesity agents and method
DE10031657A1 (de) 2000-06-29 2002-01-24 Siemens Ag Hochfrequenz-Bauelement
CA2418104A1 (en) * 2000-08-23 2002-02-28 Eli Lilly And Company Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
ME01310B (me) * 2001-05-15 2011-10-10 Hoffmann La Roche Derivati oksazola koji su supstituisani karboksilnom kiselinom za primenu kao ppar-alfa-1-gama aktivatori u lečenju dijabetesa
TWI343915B (en) * 2002-10-07 2011-06-21 Hoffmann La Roche Chirale ppar agonists

Also Published As

Publication number Publication date
KR100623819B1 (ko) 2006-09-13
CA2499721C (en) 2011-03-15
UY28006A1 (es) 2004-04-30
TW200409761A (en) 2004-06-16
KR20050055750A (ko) 2005-06-13
JP2006504709A (ja) 2006-02-09
US7348349B2 (en) 2008-03-25
AU2003273949B2 (en) 2007-04-05
IL167250A (en) 2010-12-30
US20040116487A1 (en) 2004-06-17
HK1083339A1 (en) 2006-06-30
CA2499721A1 (en) 2004-04-15
RU2005114373A (ru) 2006-05-10
AU2003273949A1 (en) 2004-04-23
NO330171B1 (no) 2011-02-28
US6969725B2 (en) 2005-11-29
CO5540385A2 (es) 2005-07-29
US20050267180A1 (en) 2005-12-01
MY143576A (en) 2011-05-31
RU2303593C2 (ru) 2007-07-27
PE20040591A1 (es) 2004-08-30
DK1551814T3 (da) 2008-10-27
EP1551814A1 (de) 2005-07-13
PL376363A1 (en) 2005-12-27
ATE402153T1 (de) 2008-08-15
ES2311110T3 (es) 2009-02-01
AR041481A1 (es) 2005-05-18
CN100415727C (zh) 2008-09-03
WO2004031162A1 (en) 2004-04-15
ZA200502664B (en) 2006-02-22
MXPA05003392A (es) 2005-06-22
EP1551814B1 (de) 2008-07-23
PT1551814E (pt) 2008-09-22
SI1551814T1 (sl) 2008-10-31
BR0315114A (pt) 2005-08-16
NO20051011L (no) 2005-05-02
DE60322408D1 (de) 2008-09-04
NZ538465A (en) 2007-08-31
PA8584501A1 (es) 2004-05-21
TWI343915B (en) 2011-06-21
CN1703406A (zh) 2005-11-30
GT200300218A (es) 2004-05-24
JP4414886B2 (ja) 2010-02-10
PL208743B1 (pl) 2011-06-30

Similar Documents

Publication Publication Date Title
NO20071042L (no) 5-substituerte 2-fenylaminobenzamider som MEK-inhibitorer
DE60329316D1 (de) Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer
HUP0101146A2 (hu) Foszfolipáz enzim inhibitor hatású indolszármazékok, valamint a vegyületeket tartalmazó gyógyászati készítmények
MA25809A1 (fr) Derives d'arylmethylamine pour usage comme inhibiteurs de tryptase
ATE185558T1 (de) Prostaglandin-synthase hemmer
YU69902A (sh) Novi derivati piperazina
BRPI0409627A (pt) 2-hidróxi-3-diaminoalcanos de fenacila
NO20053627L (no) Malonamidderivater som gamma-sekretase inhibitorer
HUP0004592A2 (hu) VCAM-1 expresszió gátlására alkalmas vegyületek és eljárások
DK0705254T3 (da) Phenylheterocykliske forbindelser som cyclooxygenase-2-inhibitorer
DK0778834T3 (da) Bicykliske, heterocykliske diarylforbindelser som inhibitorer af cyclooxygenase-2
MA29857B1 (fr) Derives de triazolopyridine en tant qu'inhibiteurs de lipases et phospholipases
MXPA05011150A (es) 2-hidroxi-3-diaminoalcanos de benzamida.
MA31873B1 (fr) Inhibiteurs de la peptide déformylase
YU59298A (sh) Postupak za dobijanje fenil heterociklusa korisnih kao inhibitora cox-2
MA30821B1 (fr) Derives de pyrazoline utiles comme antagonistes des recepteurs de mineralocorticoïdes
TR199802060T2 (xx) Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
DE60140871D1 (de) Arylmethylamin-derivate zur verwendung als inhibitoren von tryptase
ATE460394T1 (de) 5-asa-derivate mit entzündungshemmender und antibiotischer wirkung und verfahren zur behandlung von krankheiten mit diesen derivaten
HRP20050743A2 (en) 3-(2-phenyl-oxazol-4-yl methoxy) cyclohexylmethoxy acetic acid derivates and related compounds used as ppar modulators for treating type 2 diabetes and arteriosclerosis
EA200200875A1 (ru) Пролекарства производных имидазопиридина
HRP20050158A2 (en) Novel 2-arylthiazole compounds as pparalpha and ppargama agonists
DE602004010680D1 (de) Substituierte imidazopyrimidine zur prävention und behandlung von krebs
EA200000204A1 (ru) Производные пирролопирролона в качестве ингибиторов эластазы нейтрофилов
NO20051011L (no) Kirale oksazol-arylpropionsyrederivater og anvendelse derav som PPAR agonister

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20110928

Year of fee payment: 9

OBST Application withdrawn